Eli Lilly ends deal with NextCure worth up to $1.4B for the local biotech

Washington Business Journal

Jan 14, 2020

Indianapolis pharmaceutical company Eli Lilly and Co. has put the brakes on a deal potentially worth up to $1.4 billion with Beltsville biotech NextCure Inc. The local company rece…